Jessica Leininger, PharmD, MBA, BCIDP

Cluck DB, Smith J. Interactive Case: Long-Acting Lipoglycopeptides for SSTIs. Dodds Ashley ES, Gross AE, eds. In: IDSAP 2023 Book 1: SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship. ACCP; 2023. ISBN-13: 978-1-952291-72-2.

Cid A, Smetana M, Coe K, Hebert C, Smith JM. Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk. Pharmacotherapy. 2022;42(12):880-889.
Aycock A, Smith J, Coe K, Wang S, Reed E. Association between vancomycin AUC and clinical failure in patients with streptococcal bacteremia. Hospital Pharmacy. 2022;58(3):289-294. doi: 10.1177/00185787221139424.

Cash MC, Hile G, Johnson J, Stone T, Smith J, Ohl C, Luther V, Beardsley J. Sustained impact of an antibiotic stewardship initiative targeting asymptomatic bacteriuria and pyuria in the emergency department. Antimicrobial Stewardship & Healthcare Epidemiology. 2022;2(1):e148. doi: https://doi.org/10/1017/ash.2022.289
Bolker A, Coe K, Smith J, Stevenson K, Wang SH, Reed E. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagn Microbiol Infect Dis. 2022 Jan;102(1):115558. doi: 10.1016/j.diagmicrobio.2021.115558.

Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR. Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Int J Antimicrob Agents. 2021; doi: 10.1016/j.ijantimicag.2021.106.

Rinaldi A, Reed EE, Stevenson KB, Coe K, Smith JM. Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent Clostridioides difficile. J Clin Pharm Ther. 2021;00:1-6. doi: 10.1111/jcpt.13387.

Vlashyn OO, Lorenz AM, Sobhanie MM, Smith JM, Bond M, Wardlow L. Safety outcomes with high-dose daptomycin in patients with acute kidney injury and/or end-stage renal disease. J Clin Pharm Ther. 2020;00:1-6. doi: 10.1111/jcpt.13289